Insulin resistance and hepatic steatosis in ASKO mice.

Slides:



Advertisements
Similar presentations
Fig. 1. Body growth and leptin responsivity in young CPO and CTR mice
Advertisements

Peter L. Lee, Yuefeng Tang, Huawei Li, David A. Guertin 
Volume 4, Issue 12, Pages (December 2015)
Figure 1 Body weight of control and BPA-treated mothers after delivery
Volume 21, Issue 2, Pages (October 2017)
Volume 8, Issue 4, Pages (October 2008)
Volume 16, Issue 10, Pages (September 2016)
Volume 21, Issue 2, Pages (October 2017)
Ling Yang, Ping Li, Suneng Fu, Ediz S. Calay, Gökhan S. Hotamisligil 
Irs1 Serine 307 Promotes Insulin Sensitivity in Mice
Volume 18, Issue 2, Pages (August 2013)
Volume 128, Issue 5, Pages (May 2005)
TFE3 prevents diet‐induced obesity and metabolic syndrome
Impaired glucose tolerance in adult S1/3 KO mice on a normal chow
Volume 134, Issue 3, Pages (March 2008)
Volume 15, Issue 5, Pages (May 2012)
Volume 132, Issue 5, Pages (May 2007)
Volume 16, Issue 7, Pages (August 2016)
Protection against High-Fat-Diet-Induced Obesity in MDM2C305F Mice Due to Reduced p53 Activity and Enhanced Energy Expenditure  Shijie Liu, Tae-Hyung.
Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome  Xiongjie Jin, Demetrius.
Cold-Inducible SIRT6 Regulates Thermogenesis of Brown and Beige Fat
Volume 17, Issue 8, Pages (November 2016)
Volume 5, Issue 5, Pages (May 2007)
Volume 22, Issue 2, Pages (August 2015)
Volume 8, Issue 5, Pages (November 2008)
Volume 22, Issue 2, Pages (August 2015)
Hyperinsulinemic-euglycemic clamps revealed that obese TPL2KO mice have an improved insulin sensitivity compared with obese WT mice. Hyperinsulinemic-euglycemic.
Cyp8b1−/− mice have improved islet insulin secretion and increased islet insulin content but unchanged β-cell mass. Cyp8b1−/− mice have improved islet.
Exogenous CRP administration causes fasting hyperglycemia and hyperinsulinemia without altering body composition. Exogenous CRP administration causes fasting.
WASH cKO mice display a normal pancreatic development.
TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin resistance. TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin.
Sox4 promotes hepatic TG accumulation in vivo.
Modulation of insulin sensitivity by IL-6 in mice: A lack of PTP1B prevents chronic effects of IL-6. Modulation of insulin sensitivity by IL-6 in mice:
TXNIP and caspase-1 protein levels are increased in the adipose tissue of ob/ob mice. TXNIP and caspase-1 protein levels are increased in the adipose tissue.
Loss of protection by linagliptin against obesity-related inflammation and insulin resistance in MIP-1α−/− mice. Loss of protection by linagliptin against.
Glucose tolerance in WT and TRPM2-KO mice.
Transgenic restoration of long-chain n-3 PUFA protects against obesity-linked insulin resistance and glucose intolerance. Transgenic restoration of long-chain.
Fasting-induced lipolysis is impaired in weight-matched Ugcgf/f//CamKCreERT2 mice 3–4 weeks pi. Fasting-induced lipolysis is impaired in weight-matched.
Effect of berberine on white adipose tissue mass.
At 6 months of age, PPARγ deletion in late osteoblast/osteocyte controls glucose homeostasis by increasing metabolic rate and glucose uptake in WAT, BAT,
ΑGLP-1R−/− mice show glucose intolerance and disturbed glucagon secretion in response to i.p. glucose administration. αGLP-1R−/− mice show glucose intolerance.
BAFF-deficient (BAFFnull) and anti-BAFF antibody (Ab)–treated obese mice exhibit superior glucose metabolic control compared with WT and Bnull mice. BAFF-deficient.
A: Chemical structure of pterosin A
Chop deletion preserves β-cell function in P58IPK−/− mice.
Disruption of MAM integrity and insulin signaling in liver of diet-induced diabetic mice. Disruption of MAM integrity and insulin signaling in liver of.
Reduced OXPHOS expression and increased UCP expression.
USP2–45 regulates hepatic gluconeogenesis.
Effect of anandamide on blood glucose clearance and insulin sensitivity. Effect of anandamide on blood glucose clearance and insulin sensitivity. A: Intraperitoneal.
MϕRIP140KD mice show browning in vWAT.
HFD feeding induced insulin resistance in TRIB3 MOE mice.
High-glucose–induced insulin resistance in TRIB3 MOE mice.
Hepatic PPARγ deficiency impairs the SCFA-induced reduction in hepatic steatosis. Hepatic PPARγ deficiency impairs the SCFA-induced reduction in hepatic.
PEDF inhibits Wnt/T-cell factor/β-catenin signaling in resting and wounded skin. PEDF inhibits Wnt/T-cell factor/β-catenin signaling in resting and wounded.
MϕRIP140KD mice exhibit improved metabolic phenotypes.
Effects of Rosi treatment on ASKO mice.
AKT thr308 phosphorylation related to total AKT2 protein in SOL muscle (m. soleus) (A) and EDL muscle (m. extensor digitorum longus) (D) and AKT ser472.
Urinary albumin excretion and histology of glomeruli.
AP2-Cre–mediated IKKβ deletion results in similar defects in adipose remodeling and accentuated inflammatory responses after HF feeding. aP2-Cre–mediated.
Glucose-stimulated insulin secretion, plasma glucagon levels, and pancreatic hormone contents. Glucose-stimulated insulin secretion, plasma glucagon levels,
Expression of PKCδ in islets and other tissues of control and PKCδKN-overexpressing mice. Expression of PKCδ in islets and other tissues of control and.
GTTs and ITTs. A: GTTs of WT (◇), LepTg (♦), Akita (open circles), and LepTg:Akita (closed circles) mice at 8 and 16 weeks of age. GTTs and ITTs. A: GTTs.
High-fat diet–induced glucose intolerance is prevented in ghrelin knockout (Ghr-KO) mice. High-fat diet–induced glucose intolerance is prevented in ghrelin.
Loss of Phb2 in β-cells induces development of diabetes over a 3-week period in β-Phb2−/− mice. Loss of Phb2 in β-cells induces development of diabetes.
Inducible liver-specific insulin receptor knockout (iLIRKO) shows insulin resistance in the liver and extrahepatic tissues. Inducible liver-specific insulin.
IKKβ protects adipocytes from HFD-induced cell death.
Progressive IGF-1 liver expression, β-cell hyperplasia, and defective insulin secretion with aging in inducible liver-specific insulin receptor knockout.
Deficiency of adipocyte IKKβ does not affect diet-induced weigh gain but results in an exaggerated diabetic phenotype when challenged with an HFD. A: IKKβ.
MiR-200c suppresses tumor growth and metastasis of CRC in vivo by targeting Sox2. MiR-200c suppresses tumor growth and metastasis of CRC in vivo by targeting.
Fig. 4 Effects of hematopoietic restoration of TLR9 on adipose tissue inflammation and insulin resistance. Effects of hematopoietic restoration of TLR9.
Heterozygous Pik3caH1047R oncogenic mutation causes invasive prostate cancer in mice that does not phenocopy Pten deletion. Heterozygous Pik3caH1047R oncogenic.
Presentation transcript:

Insulin resistance and hepatic steatosis in ASKO mice. Insulin resistance and hepatic steatosis in ASKO mice. Glucose tolerance (A) and plasma insulin concentrations (B) during the glucose tolerance tests (GTT) and insulin tolerance tests (ITT) (C) in 3-, 6-, and 10-month-old WT and ASKO mice. M, month. Values are the mean ± SEM (n = 6). Representative Western blot images (left) for the indicated proteins in Epi-WAT (D) and liver (E) and the quantification (right) by densitometry of phosphorylated AKT (P-AKT) normalized to total AKT for 3-, 6-, and 10-month-old WT and ASKO mice. Values are the mean ± SEM, n = 4. F: Weight changes of the liver in 3-, 6-, and 10-month-old WT and ASKO mice. Liver weight is normalized to body weight. Values are the mean ± SEM (n = 9). G: Oil Red O staining of the liver from 3-, 6-, and 10-month-old WT and ASKO mice. Nuclei are counterstained with hematoxylin. The red-colored droplets represent the LD. Scale bar is 50 μm. H: Liver TAG contents from 3-, 6-, and 10-month-old WT and ASKO mice. TAG content is normalized to liver weight. Values are the mean ± SEM, n = 4–5. *P < 0.05, **P < 0.01, ***P < 0.001 for ASKO vs. WT. Lu Liu et al. Diabetes 2014;63:2320-2331 ©2014 by American Diabetes Association